These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7839411)

  • 1. In vitro recall of proliferative and cytolytic responses to minor histocompatibility antigens by dendritic cell enriched canine peripheral blood mononuclear cells.
    Kalhs P; White JS; Gervassi A; Storb R; Bean MA
    Transplantation; 1995 Jan; 59(1):112-8. PubMed ID: 7839411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minor histocompatibility antigen-specific cytotoxic T lymphocytes generated with dendritic cells from DLA-identical littermates.
    Georges GE; Lesnikova M; Storb R; Yunusov M; Little MT; Nash RA
    Biol Blood Marrow Transplant; 2003 Apr; 9(4):234-42. PubMed ID: 12720216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamma-irradiation of pretransplant blood transfusions from unrelated donors prevents sensitization to minor histocompatibility antigens on dog leukocyte antigen-identical canine marrow grafts.
    Bean MA; Graham T; Appelbaum FR; Deeg HJ; Schuening F; Sale GE; Storb R
    Transplantation; 1994 Feb; 57(3):423-6. PubMed ID: 8108879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minor histocompatibility antigens on canine hemopoietic progenitor cells.
    Weber M; Lange C; Günther W; Franz M; Kremmer E; Kolb HJ
    J Immunol; 2003 Jun; 170(12):5861-8. PubMed ID: 12794111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of transfusion-induced sensitization to minor histocompatibility antigens on DLA-identical canine marrow grafts by gamma irradiation of marrow donor blood.
    Bean MA; Storb R; Graham T; Raff R; Sale GE; Schuening F; Appelbaum FR
    Transplantation; 1991 Dec; 52(6):956-60. PubMed ID: 1836286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.
    Jin Y; Fuller L; Ciancio G; Burke GW; Tzakis AG; Ricordi C; Miller J; Esquenzai V
    Hum Immunol; 2004 Feb; 65(2):93-103. PubMed ID: 14969764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'Resistance' to unrelated, DLA-nonidentical canine marrow grafts is unrestricted by the major histocompatibility complex.
    Raff RF; Sandmaier BM; Graham T; Loughran TP; Pettinger M; Storb R
    Exp Hematol; 1994 Aug; 22(9):893-7. PubMed ID: 8062888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitization to enhanced green fluorescence protein minor histocompatibility antigen by gene transduction into dendritic cells and peritoneal exudate macrophages.
    Satoh E; Li XK; Hara Y; Ogata K; Guo L; Kitazawa Y; Funeshima-Fuji N; Satoh T; Miyagi T; Sugiura W; Yamamoto N; Teramoto K; Arii S; Kimura H
    Transpl Immunol; 2007 Nov; 18(2):73-84. PubMed ID: 18005848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferative responses of peripheral blood mononuclear cells from normal dogs and dogs with autoimmune haemolytic anaemia to red blood cell antigens.
    Corato A; Shen CR; Mazza G; Barker RN; Day MJ
    Vet Immunol Immunopathol; 1997 Nov; 59(3-4):191-204. PubMed ID: 9477471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lytic susceptibility of target cells to cytotoxic T cells is determined by their constitutive major histocompatibility complex class I antigen expression and cytokine-induced activation status.
    Ritter M; Huber C; Auböck J; Pohl-Markl H; Troppmair J; Herold M; Gächter A; Nussbaumer W; Böck G; Nachbaur D
    Immunology; 1994 Apr; 81(4):569-77. PubMed ID: 7913694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
    Tremblay N; Fontaine P; Perreault C
    Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The frequency of interferon-gproducing cells reflects alloreactivity against minor histocompatibility antigens.
    van Besouw NM; Vaessen LM; Zuijderwijk JM; van Vliet M; IJzermans JN; van Der Meide PH; Weimar W
    Transplantation; 2003 Apr; 75(8):1400-4. PubMed ID: 12717238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of cyclosporine on expression of class II major histocompatibility complex antigens on bronchoalveolar cells and peripheral blood mononuclear cells.
    Chang SC; Perng RP; Shiao GM; Lin CY
    Immunol Lett; 1990 Feb; 23(4):299-303. PubMed ID: 2347605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary proliferative and cytotoxic T-cell responses to HIV induced in vitro by human dendritic cells.
    Macatonia SE; Patterson S; Knight SC
    Immunology; 1991 Nov; 74(3):399-406. PubMed ID: 1769689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfusion of autologous cytotoxic cells leads to failure of unrelated, DLA-nonidentical marrow grafts.
    Loughran TP; Raff RF; Graham TC; Appelbaum FR; Schuening FG; Sale GE; Storb R
    Exp Hematol; 1990 Nov; 18(10):1126-31. PubMed ID: 2209768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graft-versus-host disease associated T helper cell responses specific for minor histocompatibility antigens are mainly restricted by HLA-DR molecules.
    van Els CA; Zantvoort E; Jacobs N; Bakker A; van Rood JJ; Goulmy E
    Bone Marrow Transplant; 1990 Jun; 5(6):365-72. PubMed ID: 2142441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth inhibition of clonogenic leukemic precursor cells by minor histocompatibility antigen-specific cytotoxic T lymphocytes.
    Falkenburg JH; Goselink HM; van der Harst D; van Luxemburg-Heijs SA; Kooy-Winkelaar YM; Faber LM; de Kroon J; Brand A; Fibbe WE; Willemze R
    J Exp Med; 1991 Jul; 174(1):27-33. PubMed ID: 2056279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
    J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunodominant minor histocompatibility antigen peptides recognized by cytolytic T lymphocytes primed by indirect presentation.
    Nevala WK; Paul C; Wettstein PJ
    Transplantation; 1998 Feb; 65(4):559-69. PubMed ID: 9500633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canine dendritic cells from peripheral blood and lymph nodes.
    Goodell EM; Blumenstock DA; Bowers WE
    Vet Immunol Immunopathol; 1985 Apr; 8(4):301-10. PubMed ID: 3159147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.